这些交易是Isomorphic构建「世界级药物设计引擎」计划的一部分——一个将机器学习研究人员与制药业资深人士结合的系统，旨在更快、更便宜、更高成功率地设计新药。

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

刚刚，AI制药从理论迈向实践的关键一步！DeepMind分拆公司，亮出「秘密武器」：基于AlphaFold系统研发的候选药物，已进入人体临床实验。这意味着将大幅缩短新药研发周期、降低成本，加速新药惠及患者。

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Scientists unite to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...